This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
hiv aids | 1578 |
public health | 536 |
health care | 488 |
hiv infection | 420 |
infectious diseases | 326 |
immunodeficiency virus | 324 |
united states | 320 |
human immunodeficiency | 293 |
infected patients | 205 |
aids patients | 182 |
human rights | 181 |
antiretroviral therapy | 181 |
infectious disease | 178 |
global fund | 163 |
aids epidemic | 144 |
developing countries | 141 |
virus infection | 140 |
global health | 137 |
world health | 116 |
hiv transmission | 115 |
sex workers | 114 |
people living | 113 |
hiv testing | 113 |
drug users | 105 |
mental health | 105 |
infected individuals | 105 |
cell count | 104 |
opportunistic infections | 103 |
acquired immunodeficiency | 102 |
immunodeficiency syndrome | 100 |
health organization | 92 |
world bank | 91 |
risk factors | 91 |
cryptococcal meningitis | 88 |
new york | 87 |
hiv patients | 85 |
spontaneous pneumothorax | 85 |
hiv prevention | 84 |
immune system | 84 |
united nations | 84 |
aids prevention | 83 |
hiv disease | 82 |
emerging infectious | 80 |
weight loss | 80 |
cord uid | 79 |
doc id | 79 |
saharan africa | 78 |
civil society | 78 |
aids related | 75 |
alcohol use | 74 |
immune reconstitution | 73 |
gastrointestinal tract | 72 |
immune response | 72 |
acute respiratory | 71 |
virus type | 70 |
primary health | 70 |
pneumocystis carinii | 69 |
fi ndings | 67 |
viral load | 67 |
infected children | 66 |
south africa | 65 |
disease control | 64 |
lung cancer | 63 |
hiv cases | 63 |
drug use | 62 |
immune responses | 61 |
health services | 61 |
private sector | 60 |
clinical trials | 59 |
hiv infected | 59 |
may also | 58 |
fractional order | 58 |
hiv status | 58 |
general population | 58 |
herpes simplex | 58 |
chinese government | 58 |
international community | 57 |
nervous system | 56 |
highly active | 55 |
cd cell | 55 |
ist die | 55 |
infi ltration | 54 |
respiratory syndrome | 53 |
condom use | 52 |
rhodococcus equi | 51 |
million people | 51 |
cd counts | 51 |
universal arv | 51 |
carinii pneumonia | 50 |
increased risk | 50 |
central nervous | 50 |
active antiretroviral | 50 |
income countries | 48 |
homosexual men | 48 |
immune activation | 48 |
tmp smx | 47 |
severe acute | 47 |
arv access | 47 |
chest pain | 47 |
bacterial pneumonia | 46 |
cells ml | 46 |
high risk | 46 |
lymph nodes | 46 |
physical health | 46 |
mycobacterium avium | 45 |
control measures | 44 |
immune deficiency | 44 |
aids pandemic | 44 |
optimal control | 44 |
multiple sclerosis | 43 |
sexually transmitted | 43 |
immunodefi ciency | 43 |
ciency virus | 43 |
health policy | 43 |
aids response | 42 |
parenchymal changes | 42 |
may occur | 42 |
mg kg | 41 |
ct scanning | 41 |
york city | 41 |
care providers | 41 |
cryptococcus neoformans | 41 |
disease progression | 40 |
aged years | 40 |
hiv prevalence | 40 |
emerging infections | 40 |
chronic diarrhea | 40 |
side effects | 40 |
risk groups | 40 |
health problems | 40 |
hiv positive | 40 |
communicable diseases | 39 |
inflammatory syndrome | 39 |
aids diagnosis | 39 |
informed consent | 39 |
care services | 39 |
cd count | 39 |
reconstitution inflammatory | 38 |
per year | 38 |
hiv infections | 38 |
systematic review | 38 |
mycobacterium tuberculosis | 38 |
poster sessions | 37 |
fi brosis | 37 |
universal primary | 37 |
bei der | 37 |
und die | 36 |
clinical manifestations | 36 |
chez les | 36 |
health status | 36 |
years ago | 36 |
necrosis factor | 36 |
sadc countries | 36 |
progressive multifocal | 36 |
pleural effusion | 36 |
developed countries | 35 |
cd lymphocyte | 35 |
health outcomes | 35 |
immunocompromised patients | 35 |
related pulmonary | 35 |
international health | 35 |
health promotion | 35 |
mortality rate | 35 |
bone marrow | 35 |
secondary prophylaxis | 35 |
health systems | 35 |
durch die | 34 |
aids programs | 34 |
urban areas | 34 |
posttraumatic growth | 34 |
infectious agents | 34 |
respiratory tract | 34 |
von der | 34 |
multifocal leukoencephalopathy | 34 |
social services | 34 |
study group | 34 |
incubation period | 34 |
high levels | 34 |
mortality rates | 33 |
hiv vaccine | 33 |
pulmonary tuberculosis | 33 |
cmv retinitis | 33 |
among hiv | 33 |
pathological changes | 33 |
norm entrepreneurs | 33 |
injection drug | 33 |
peripheral blood | 33 |
united kingdom | 33 |
fungal infections | 33 |
personal autonomy | 33 |
rmatively diagnosed | 32 |
primary care | 32 |
hiv epidemic | 32 |
health workers | 32 |
drug resistance | 32 |
cells mm | 32 |
vulnerable groups | 32 |
cryptococcal infection | 32 |
tumor necrosis | 32 |
pregnant women | 32 |
kommt es | 32 |
chest radiograph | 32 |
community health | 32 |
confi rmatively | 32 |
west nile | 32 |
vaccine development | 31 |
bal fluid | 31 |
injecting drug | 31 |
acquired immune | 31 |
advanced hiv | 31 |
patient aged | 31 |
cell vaccination | 31 |
avian influenza | 31 |
perceived severity | 31 |
urban health | 30 |
grassroots ngos | 30 |
medical care | 30 |
san francisco | 30 |
even though | 30 |
les patients | 30 |
controlled trial | 30 |
fl uid | 30 |
bacterial infections | 30 |
simplex virus | 30 |
lymph node | 30 |
health service | 30 |
opportunistic infection | 30 |
mg day | 30 |
north america | 30 |
sars outbreak | 30 |
protease inhibitors | 30 |
maintenance therapy | 30 |
antiretroviral treatment | 29 |
care system | 29 |
global hiv | 29 |
small intestine | 29 |
alcohol consumption | 29 |
clinical symptoms | 29 |
fl aky | 29 |
breast cancer | 29 |
small bowel | 29 |
cohort study | 29 |
abdominal pain | 29 |
endemic areas | 29 |
ist eine | 29 |
oral health | 28 |
fi ciency | 28 |
health governance | 28 |
cardiovascular disease | 28 |
emerging diseases | 28 |
immunode fi | 28 |
national hiv | 28 |
latin america | 28 |
patients infected | 28 |
infl ammation | 28 |
patients receiving | 28 |
blood products | 28 |
low cd | 28 |
poor countries | 27 |
prospective study | 27 |
life expectancy | 27 |
endemic equilibrium | 27 |
health centre | 27 |
th century | 27 |
respiratory distress | 27 |
antifungal therapy | 27 |
patients may | 27 |
der hiv | 27 |
may cause | 27 |
viral infections | 26 |
street youth | 26 |
deficiency syndrome | 26 |
health system | 26 |
avium complex | 26 |
hong kong | 26 |
cell counts | 26 |
south america | 26 |
pulmonary disease | 26 |
staphylococcus aureus | 26 |
many countries | 26 |
randomized trial | 26 |
health needs | 26 |
viral replication | 26 |
universal access | 26 |
vor allem | 26 |
commercial sex | 26 |
simian immunodeficiency | 26 |
zhao ping | 26 |
epidemic model | 26 |
epithelial cells | 26 |
type i | 25 |
health problem | 25 |
natural history | 25 |
disseminated histoplasmosis | 25 |
disease outbreaks | 25 |
substance use | 25 |
nile virus | 25 |
transplant recipients | 25 |
pulmonary edema | 25 |
working group | 25 |
inner city | 25 |
pulmonary infection | 25 |
leading cause | 25 |
pulmonary infections | 25 |
surveillance system | 25 |
antiretroviral drugs | 25 |
polysaccharide antigen | 25 |
body mass | 25 |
chest tube | 25 |
social support | 24 |
haart era | 24 |
south african | 24 |
child transmission | 24 |
early stage | 24 |
reproductive health | 24 |
mit der | 24 |
focused ngos | 24 |
will continue | 24 |
alternative medicines | 24 |
effect size | 24 |
specified infections | 24 |
important role | 24 |
lamina propria | 24 |
viral infection | 24 |
long term | 24 |
case fatality | 24 |
negative mental | 24 |
health professionals | 24 |
harm reduction | 24 |
commonly used | 24 |
logistic regression | 24 |
noninfectious diarrhea | 24 |
preventive measures | 24 |
diffi culty | 24 |
developing nations | 23 |
new infections | 23 |
health centers | 23 |
aber auch | 23 |
perceived susceptibility | 23 |
fi rst | 23 |
intravenous drug | 23 |
diagnostic imaging | 23 |
gi tract | 23 |
national governments | 23 |
hiv viral | 23 |
health education | 23 |
ciency syndrome | 23 |
fight aids | 23 |
cerebrospinal fluid | 23 |
two decades | 23 |
aids cases | 23 |
liver disease | 23 |
statistically significant | 23 |
developing world | 23 |
new hiv | 23 |
bronchoalveolar lavage | 23 |
lymphocyte counts | 23 |
sex work | 23 |
large quantity | 23 |
animal models | 23 |
human immunodefi | 23 |
defi ne | 23 |
social justice | 23 |
patients sida | 23 |
diffi cult | 22 |
gastrointestinal symptoms | 22 |
cryptococcal antigen | 22 |
national health | 22 |
aids vaccine | 22 |
ground glass | 22 |
fractional optimal | 22 |
hiv surveillance | 22 |
kg day | 22 |
risk factor | 22 |
blood safety | 22 |
nutritional status | 22 |
health issues | 22 |
distress syndrome | 22 |
state council | 22 |
glass liked | 22 |
cell responses | 22 |
measles virus | 22 |
female sex | 22 |
recent study | 22 |
general assembly | 22 |
infected persons | 22 |
without aids | 22 |
positive patients | 22 |
global burden | 22 |
family planning | 22 |
randomized controlled | 22 |
skin test | 21 |
clinical disease | 21 |
blood donors | 21 |
aids clinical | 21 |
infected cells | 21 |
differential diagnosis | 21 |
primary prophylaxis | 21 |
sars epidemic | 21 |
first time | 21 |
patienten mit | 21 |
take care | 21 |
interstitial pneumonia | 21 |
mit einer | 21 |
sexual transmission | 21 |
gates foundation | 21 |
urban poor | 21 |
medical services | 21 |
dendritic cells | 21 |
aids policies | 21 |
among women | 21 |
high fever | 21 |
west africa | 21 |
blood transfusion | 21 |
service providers | 21 |
health insurance | 21 |
differential equations | 21 |
infected adults | 21 |
effect sizes | 21 |
findings suggest | 20 |
immune function | 20 |
treatment programs | 20 |
active tuberculosis | 20 |
effector cells | 20 |
needle exchange | 20 |
british columbia | 20 |
clinical practice | 20 |
transmitted diseases | 20 |
cd cells | 20 |
presentation will | 20 |
among patients | 20 |
socioeconomic status | 20 |
less likely | 20 |
st century | 20 |
infl ammatory | 20 |
ebola virus | 20 |
industrialized countries | 20 |
cytomegalovirus retinitis | 20 |
bei hiv | 20 |
hiv treatment | 20 |
kaposi sarcoma | 20 |
care workers | 20 |
high rates | 20 |
lung fi | 20 |
tuberculosis infection | 19 |
one study | 19 |
sexual partners | 19 |
clinical trial | 19 |
clinical features | 19 |
sind die | 19 |
economic development | 19 |
young people | 19 |
asymptotically stable | 19 |
per day | 19 |
child health | 19 |
positive mental | 19 |
lean body | 19 |
human immunode | 19 |
young girls | 19 |
aids denial | 19 |
among men | 19 |
infectious agent | 19 |
lung tissues | 19 |
public image | 19 |
aids ngos | 19 |
positive individuals | 19 |
mononuclear cells | 19 |
disease may | 19 |
communicable disease | 19 |
die therapie | 19 |
service delivery | 19 |
recent years | 19 |
chronic hepatitis | 19 |
infection among | 19 |
aids treatment | 19 |
auf die | 19 |
first century | 19 |
blood cd | 19 |
early diagnosis | 19 |
regulatory network | 19 |
social capital | 19 |
among people | 19 |
low income | 19 |
disease outbreak | 19 |
male patient | 19 |
will also | 18 |
large numbers | 18 |
rural areas | 18 |
case studies | 18 |
drug abuse | 18 |
trials group | 18 |
data collection | 18 |
tubercle bacilli | 18 |
und der | 18 |
melinda gates | 18 |
health regulations | 18 |
national security | 18 |
behavioral change | 18 |
international guidelines | 18 |
virus infections | 18 |
vertical transmission | 18 |
made available | 18 |
imaging fi | 18 |
present study | 18 |
chronic disease | 18 |
national aids | 18 |
aids complicated | 18 |
psychological adjustment | 18 |
prophylactic vaccine | 18 |
coinfected patients | 18 |
nachweis von | 18 |
respiratory failure | 18 |
influenza pandemic | 18 |
will provide | 18 |
publication bias | 18 |
southeast asia | 18 |
fractional derivative | 18 |
drug interactions | 18 |
shock syndrome | 18 |
positive people | 18 |
vector control | 18 |
chest distress | 18 |
new disease | 18 |
muscle proteolysis | 18 |
disseminated disease | 17 |
drug treatment | 17 |
last years | 17 |
million persons | 17 |
new cases | 17 |
die diagnose | 17 |
high prevalence | 17 |
imaging demonstrations | 17 |
government officials | 17 |
pulmonary toxoplasmosis | 17 |
sexual intercourse | 17 |
way forward | 17 |
diarrheal diseases | 17 |
viral hepatitis | 17 |
pulmonary aspergillosis | 17 |
feline immunodeficiency | 17 |
primary infection | 17 |
human beings | 17 |
count cells | 17 |
esophageal candidiasis | 17 |
laboratory systems | 17 |
insulin resistance | 17 |
widespread use | 17 |
neutralizing antibodies | 17 |
ist der | 17 |
hiv test | 17 |
ray demonstrates | 17 |
disease surveillance | 17 |
focus groups | 17 |
per cent | 17 |
associated cryptococcal | 17 |
member states | 17 |
laboratory tests | 17 |
equity health | 17 |
african american | 17 |
safe sex | 17 |
plasmid dna | 17 |
cryptosporidium parvum | 17 |
bacterial overgrowth | 17 |
effective prevention | 17 |
local health | 17 |
lymphocyte count | 17 |
electron microscopy | 17 |
large number | 17 |
combination therapy | 17 |
mit dem | 17 |
aids care | 17 |
hemorrhagic fever | 17 |
identifi ed | 17 |
simplex viral | 17 |
advisory committee | 16 |
development goals | 16 |
use among | 16 |
seropositive patients | 16 |
viral pneumonia | 16 |
fi elds | 16 |
free equilibrium | 16 |
factors associated | 16 |
may lead | 16 |
disease prevention | 16 |
china cdc | 16 |
past years | 16 |
pandemic influenza | 16 |
million new | 16 |
surveillance data | 16 |
air leak | 16 |
become infected | 16 |
least one | 16 |
criminal law | 16 |
cryptococcal polysaccharide | 16 |
alcohol intake | 16 |
transmitted infections | 16 |
aus der | 16 |
arv treatment | 16 |
study showed | 16 |
common cause | 16 |
reverse transcriptase | 16 |
autoimmune diseases | 16 |
chest radiographs | 16 |
effective treatment | 16 |
causative agent | 16 |
world war | 16 |
second life | 16 |
rhesus macaques | 16 |
infected individual | 16 |
social stigma | 16 |
african countries | 16 |
national institutes | 16 |
jakob disease | 16 |
middle east | 16 |
cmv infection | 16 |
chloroquine hydroxychloroquine | 16 |
intervention group | 16 |
urban settings | 16 |
dengue fever | 16 |
treatment strategy | 16 |
years old | 16 |
national institute | 16 |
yellow fever | 16 |
infi ltrative | 16 |
prevention programs | 16 |
chinese women | 16 |
nodular shadows | 16 |
mechanical ventilation | 16 |
also cause | 15 |
associated diarrhea | 15 |
patients treated | 15 |
rheumatoid arthritis | 15 |
immunosuppressed patients | 15 |
helicobacter pylori | 15 |
le plus | 15 |
tb control | 15 |
mucosal immunity | 15 |
blood supply | 15 |
nongovernmental organizations | 15 |
xiao lu | 15 |
control problem | 15 |
type ii | 15 |
sexual behavior | 15 |
histoplasma capsulatum | 15 |
autoimmune disease | 15 |
miliary tuberculosis | 15 |
also found | 15 |
action plan | 15 |
microbial threats | 15 |
future research | 15 |
four times | 15 |
based hiv | 15 |
chronic diseases | 15 |
public policy | 15 |
advanced stage | 15 |
cervical cancer | 15 |
male circumcision | 15 |
years later | 15 |
also occur | 15 |
health programs | 15 |
organ transplant | 15 |
ethnic minority | 15 |
antibody response | 15 |
gibt es | 15 |
sexual health | 15 |
human herpesvirus | 15 |
nucleic acid | 15 |
surveillance systems | 15 |
travel restrictions | 15 |
substance abuse | 15 |
cause disease | 15 |
two years | 15 |
oropharyngeal candidiasis | 15 |
governmental organizations | 15 |
population health | 15 |
viral vectors | 15 |
criminal laws | 15 |
combined testing | 15 |
regression analysis | 15 |
health policies | 15 |
one third | 15 |
unprotected sex | 15 |
higher risk | 15 |
infection may | 15 |
des patients | 15 |
prevention strategies | 15 |
amino acid | 15 |
health information | 15 |
hiv tests | 15 |
population groups | 15 |
policy makers | 15 |
rapid progression | 15 |
public security | 15 |
experimental autoimmune | 15 |
siv infection | 15 |
gene expression | 15 |
financial resources | 15 |
scanning demonstrates | 15 |
pulmonary cryptococcosis | 15 |
pleural space | 15 |
pulmonary interstitial | 14 |
cell lines | 14 |
domestic cat | 14 |
heart disease | 14 |
lassa fever | 14 |
see table | 14 |
government agencies | 14 |
pilot study | 14 |
mediated immunity | 14 |
toxic shock | 14 |
security council | 14 |
infected person | 14 |
prevent hiv | 14 |
reported cases | 14 |
plus fr | 14 |
related ngos | 14 |
enteric infections | 14 |
transbronchial biopsy | 14 |
north american | 14 |
toxoplasma gondii | 14 |
vaccine candidates | 14 |
wasting syndrome | 14 |
ethical issues | 14 |
global aids | 14 |
sample size | 14 |
controlled trials | 14 |
several years | 14 |
widely used | 14 |
aids stage | 14 |
risk behaviors | 14 |
sovereign dignity | 14 |
acute onset | 14 |
best practices | 14 |
candida albicans | 14 |
mit einem | 14 |
lung disease | 14 |
persons living | 14 |
liked shadows | 14 |
capacity building | 14 |
based research | 14 |
acquired immunodefi | 14 |
environmental factors | 14 |
effective hiv | 14 |
aids policy | 14 |
large fl | 14 |
major cause | 14 |
mathematical models | 14 |
international development | 14 |
water supplies | 14 |
research project | 14 |
cell depletion | 14 |
exposed individuals | 14 |
naturally occurring | 14 |
health authorities | 14 |
los angeles | 14 |
like particles | 14 |
clinton foundation | 14 |
medical mistrust | 14 |
antibiotic therapy | 14 |
infected population | 14 |
economic reform | 14 |
auch die | 14 |
crisis management | 14 |
southern africa | 14 |
community members | 14 |
may result | 14 |
infected subjects | 14 |
central type | 14 |
new norm | 14 |
protease inhibitor | 14 |
fatality rate | 14 |
service provision | 14 |
mediastinal lymphadenectasis | 14 |
ata declaration | 14 |
hiv rna | 14 |
clostridium difficile | 14 |
heart failure | 14 |
developed states | 14 |
homeless people | 14 |
three times | 14 |
bei den | 14 |
biological weapons | 14 |
respiratory disease | 14 |
supreme court | 13 |
global business | 13 |
severe disease | 13 |
many parts | 13 |
common good | 13 |
promising results | 13 |
monoclonal antibodies | 13 |
past decade | 13 |
drinking water | 13 |
respiratory symptoms | 13 |
enteric pathogens | 13 |
penicillium marneffei | 13 |
equi infection | 13 |
asian msm | 13 |
hpa axis | 13 |
prevention efforts | 13 |
version posted | 13 |
fl ow | 13 |
hemmung der | 13 |
will help | 13 |
forward prevention | 13 |
infected people | 13 |
many people | 13 |
cause diarrhea | 13 |
statistical methods | 13 |
health risks | 13 |
rapid diagnosis | 13 |
eastern europe | 13 |
second quarter | 13 |
wide range | 13 |
medication adherence | 13 |
geographical expansion | 13 |
infection control | 13 |
primary pulmonary | 13 |
control strategy | 13 |
aids transmission | 13 |
polymerase chain | 13 |
healthcare services | 13 |
hiv pandemic | 13 |
copyright holder | 13 |
million cases | 13 |
effective antiretroviral | 13 |
live attenuated | 13 |
aids patient | 13 |
urban communities | 13 |
reporting system | 13 |
female patient | 13 |
author funder | 13 |
retroviral therapy | 13 |
twentieth century | 13 |
hiv related | 13 |
social workers | 13 |
antimicrobial resistance | 13 |
pediatric aids | 13 |
nations international | 13 |
health infrastructure | 13 |
global governance | 13 |
directly observed | 13 |
human body | 13 |
severe cases | 13 |
several studies | 13 |
induction therapy | 13 |
among msm | 13 |
international license | 13 |
pulmonary interstitium | 13 |
bronchial pneumonia | 13 |
lymphoid tissue | 13 |
seropositive individuals | 13 |
international organizations | 13 |
au niveau | 13 |
sars coronavirus | 13 |
soviet union | 13 |
granted medrxiv | 13 |
auch bei | 13 |
intensive care | 13 |
living conditions | 13 |
basic reproduction | 13 |
national level | 13 |
syringe exchange | 13 |
enteric infection | 13 |
combination antiretroviral | 13 |
mg orally | 13 |
aus dem | 13 |
disease caused | 13 |
durch den | 13 |
private partnerships | 13 |
transmission dynamics | 13 |
health sector | 12 |
fractional differential | 12 |
health research | 12 |
india ink | 12 |
disease severity | 12 |
poorly informed | 12 |
hazardous drinking | 12 |
tissue culture | 12 |
consent requirements | 12 |
je nach | 12 |
hcv infection | 12 |
determine whether | 12 |
early stages | 12 |
upper gastrointestinal | 12 |
developed world | 12 |
pathogenic bacteria | 12 |
mycoses study | 12 |
order desires | 12 |
among persons | 12 |
disease transmission | 12 |
reemerging diseases | 12 |
infection status | 12 |
hiv replication | 12 |
newly emerging | 12 |
highly correlation | 12 |
neutralizing antibody | 12 |
effectiveness level | 12 |
posted october | 12 |
population density | 12 |
policy implementation | 12 |
susceptible individuals | 12 |
qualitative study | 12 |
random sample | 12 |
less effective | 12 |
sexual risk | 12 |
blurry boundaries | 12 |
human population | 12 |
smoking cessation | 12 |
polio vaccine | 12 |
symptoms include | 12 |
economic burden | 12 |
better understanding | 12 |
aids mortality | 12 |
care systems | 12 |
colleagues found | 12 |
age group | 12 |
first described | 12 |
small number | 12 |
may produce | 12 |
east asia | 12 |
signaling systems | 12 |
local funding | 12 |
high incidence | 12 |
gastrointestinal infections | 12 |
benefit finding | 12 |
aids relief | 12 |
clinical presentation | 12 |
chain reaction | 12 |
diagnostic tests | 12 |
body fluids | 12 |
control group | 12 |
disseminated infection | 12 |
air leaks | 12 |
well known | 12 |
nach der | 12 |
case study | 12 |
host immune | 12 |
mac infection | 12 |
national laboratory | 12 |
risk behaviours | 12 |
counts cells | 12 |
exchange programs | 12 |
prevalence rates | 12 |
vaccine vectors | 12 |
among young | 12 |
und auch | 12 |
clinical course | 12 |
per month | 12 |
es sich | 12 |
puerto rico | 12 |
social marketing | 12 |
food insecurity | 12 |
ngos working | 12 |
aids drugs | 12 |
emerging disease | 12 |
rights watch | 12 |
cancer patients | 12 |
society organizations | 12 |
among children | 12 |
reported hiv | 12 |
vaccinia virus | 12 |
dengue virus | 12 |
stool specimens | 12 |
positive changes | 12 |
defi ned | 12 |
physical activity | 12 |
dna vaccines | 12 |
us government | 12 |
currently available | 12 |
may present | 12 |
von den | 12 |
barr virus | 12 |
many women | 12 |
auf der | 12 |
public good | 12 |
lung tissue | 11 |
negative patients | 11 |
im gegensatz | 11 |
median age | 11 |
sexual activity | 11 |
tropical diseases | 11 |
immune dysfunction | 11 |
culty breathing | 11 |
sterilizing immunity | 11 |
sich um | 11 |
also known | 11 |
primary spontaneous | 11 |
better understand | 11 |
significantly higher | 11 |
small intestinal | 11 |
two main | 11 |
will take | 11 |
liver fi | 11 |
envelope glycoprotein | 11 |
develop aids | 11 |
diagnostic yield | 11 |
asymptomatic hiv | 11 |
aids research | 11 |
hiv response | 11 |
time since | 11 |
gene transfer | 11 |
new era | 11 |
tube thoracostomy | 11 |
year action | 11 |
sentinel surveillance | 11 |
der nachweis | 11 |
aids interventions | 11 |
health agencies | 11 |
major role | 11 |
improve health | 11 |
host cell | 11 |
globally asymptotically | 11 |
novel coronavirus | 11 |
family members | 11 |
active tb | 11 |
subunit vaccines | 11 |
enterocytozoon bieneusi | 11 |
variant creutzfeldt | 11 |
million hiv | 11 |
vast majority | 11 |
young children | 11 |
least months | 11 |
risk populations | 11 |
positive psychological | 11 |
early treatment | 11 |
related deaths | 11 |
pulmonary markings | 11 |
lower respiratory | 11 |
associated herpesvirus | 11 |
equilibrium points | 11 |
related tuberculosis | 11 |
dying kiss | 11 |
acute infection | 11 |
increased susceptibility | 11 |
became infected | 11 |
mental disorders | 11 |
community capacity | 11 |
significantly associated | 11 |
high mortality | 11 |
lower lung | 11 |
cryptosporidium infection | 11 |
prevention working | 11 |
sex education | 11 |
disease study | 11 |
moist rales | 11 |
less common | 11 |
focus group | 11 |
million deaths | 11 |
endothelial cells | 11 |
health initiative | 11 |
genital herpes | 11 |
hiv serology | 11 |
treatment options | 11 |
sexual abuse | 11 |
dry cough | 11 |
related stigma | 11 |
increasing number | 11 |
human services | 11 |
women living | 11 |
health threat | 11 |
converting enzyme | 11 |
unwanted sexual | 11 |
total number | 11 |
health measures | 11 |
tension pneumothorax | 11 |
resistant tuberculosis | 11 |
blood cultures | 11 |
young adults | 11 |
stability analysis | 11 |
signifi cant | 11 |
literature review | 11 |
antigen presentation | 11 |
national pride | 11 |
significantly lower | 11 |
ill patients | 11 |
health concerns | 11 |
simple aspiration | 11 |
und eine | 11 |
new diseases | 11 |
discourse analysis | 11 |
developing states | 11 |
leptin levels | 11 |
contracted hiv | 11 |
numerical results | 11 |
grade fever | 11 |
suppressor cells | 11 |
high level | 11 |
health implications | 11 |
disseminated coccidioidomycosis | 11 |
der infektion | 11 |
individuals unaware | 11 |
sexual contact | 11 |
gastrointestinal disease | 11 |
several weeks | 11 |
vaccine efficacy | 11 |
weight gain | 11 |
black death | 11 |
illicit drug | 11 |
environmental health | 11 |
religion scholars | 11 |
preventive action | 11 |
results suggest | 11 |
randomized study | 11 |
per capita | 11 |
hazardous alcohol | 11 |
emergency plan | 11 |
im blut | 11 |
data analysis | 10 |
disease emergence | 10 |
health community | 10 |
physical examination | 10 |
year period | 10 |
aids epidemics | 10 |
human disease | 10 |
fatality rates | 10 |
water supply | 10 |
avium intracellulare | 10 |
us department | 10 |
crack users | 10 |
cell function | 10 |
cellular immunity | 10 |
lung injury | 10 |
social consequences | 10 |
estimated million | 10 |
bei immunsupprimierten | 10 |
therapy may | 10 |
um eine | 10 |
defi nitive | 10 |
first identified | 10 |
drug administration | 10 |
spongiform encephalopathy | 10 |
including hiv | 10 |
aids prevalence | 10 |
aids knowledge | 10 |
major public | 10 |
health security | 10 |
us billion | 10 |
cell activation | 10 |
new immigrants | 10 |
target population | 10 |
cell membrane | 10 |
mean age | 10 |
der therapie | 10 |
three main | 10 |
intestinal tract | 10 |
human life | 10 |
care needs | 10 |
pediatric hiv | 10 |
food security | 10 |
bacterial infection | 10 |
obstructive pneumonia | 10 |
case finding | 10 |
increased incidence | 10 |
body weight | 10 |
numerical simulations | 10 |
biliary tract | 10 |
rights norms | 10 |
issues surrounding | 10 |
protective effect | 10 |
support services | 10 |
total population | 10 |
blood pressure | 10 |
testing methods | 10 |
epidemic intelligence | 10 |
hiv diagnosis | 10 |
aids wasting | 10 |
millennium development | 10 |
two groups | 10 |
knockout mutants | 10 |
security threat | 10 |
months later | 10 |
high school | 10 |
may help | 10 |
deaths per | 10 |
catamenial pneumothorax | 10 |
study found | 10 |
poor settings | 10 |
needle aspiration | 10 |
first step | 10 |
opportunistic disease | 10 |
intestinal mucosa | 10 |
vulnerable populations | 10 |
viral disease | 10 |
cytotoxic cells | 10 |
many patients | 10 |
vaccine design | 10 |
disseminated mycobacterium | 10 |
social distancing | 10 |
community level | 10 |
health officials | 10 |
numerical solution | 10 |
initial infection | 10 |
malaria control | 10 |
transmission rate | 10 |
disease among | 10 |
fi brous | 10 |
clinical diagnosis | 10 |
disease spread | 10 |
treatment failure | 10 |
transcriptional activity | 10 |
mehr als | 10 |
national government | 10 |
epidemic diseases | 10 |
effective vaccine | 10 |
times daily | 10 |
antiretroviralen therapie | 10 |
chronic hiv | 10 |
leukemia virus | 10 |
great deal | 10 |
chemokine receptor | 10 |
health interventions | 10 |
type infection | 10 |
cd lymphocytes | 10 |
global public | 10 |
caputo fractional | 10 |
imaging demonstrates | 10 |
sex worker | 10 |
protective immunity | 10 |
bilateral pneumothoraces | 10 |
successful treatment | 10 |
air pollution | 10 |
cytokine production | 10 |
immune hyperactivation | 10 |
central america | 10 |
escherichia coli | 10 |
children aged | 10 |
feeding tube | 10 |
specific immune | 10 |
hiv enteropathy | 10 |
infections may | 10 |
aids crisis | 10 |
fr quemment | 10 |
nur bei | 10 |
pleural fl | 10 |
social determinants | 10 |
reconstitution syndrome | 10 |
drug therapy | 10 |
lassen sich | 10 |
educational level | 10 |
starting point | 10 |
und bei | 10 |
nurse practitioner | 10 |
virus acquired | 10 |
working together | 10 |
people infected | 10 |
underlying lung | 10 |
gender inequality | 10 |
help us | 10 |
five years | 10 |
human right | 10 |
influenza virus | 10 |
clinical research | 10 |
decision making | 10 |
heterosexual transmission | 10 |
envelope protein | 10 |
care settings | 10 |
white matter | 10 |
aids program | 10 |
health survey | 10 |
vaccine candidate | 10 |
related diseases | 10 |
preliminary results | 10 |
state actors | 10 |
prevalence among | 10 |
sustainable development | 10 |
dans les | 10 |
health emergency | 10 |
oral candidiasis | 10 |
medical pseudoscience | 10 |
mathematical model | 10 |
study conducted | 10 |
resistant strains | 10 |
hiv antigens | 10 |
effi cacy | 10 |
den usa | 10 |
economic impact | 10 |
le diagnostic | 10 |
well tolerated | 10 |
pcp prophylaxis | 10 |
therapeutic intervention | 10 |
toxoplasmic encephalitis | 10 |
hivinfected patients | 10 |
virus disease | 10 |
gay men | 10 |
health crisis | 10 |
cerebral toxoplasmosis | 10 |
contracting hiv | 10 |
laboratory services | 10 |
positive children | 10 |
business coalition | 10 |
adverse effects | 10 |
chinese society | 10 |
viral reservoir | 10 |
colleagues reported | 10 |
fungal infection | 10 |
candida esophagitis | 10 |
much higher | 10 |
human infection | 10 |
usd million | 10 |
alcohol abuse | 10 |
ethnic groups | 10 |
specific health | 10 |
population effect | 10 |
many years | 10 |
diffuse interstitial | 10 |
gabe von | 10 |
conspiracy beliefs | 10 |
recurrent pneumothorax | 10 |
fi stula | 10 |
moulton method | 10 |
die meisten | 10 |
esophageal ulceration | 10 |
hiv risk | 9 |
watery diarrhea | 9 |
commonly found | 9 |
aspergillus fumigatus | 9 |
greatest risk | 9 |
classifi ed | 9 |
critically ill | 9 |
two types | 9 |
class i | 9 |
human populations | 9 |
health behavior | 9 |
liked changes | 9 |
york times | 9 |
inclusion bodies | 9 |
latent tuberculosis | 9 |
behandelt werden | 9 |
reproduction number | 9 |
another study | 9 |
imaging examinations | 9 |
surgeon general | 9 |
nach einer | 9 |
tract infection | 9 |
aids control | 9 |
wie bei | 9 |
prenatal care | 9 |
three major | 9 |
mental status | 9 |
cultural values | 9 |
related complex | 9 |
among health | 9 |
oral thrush | 9 |
hemorrhagic fevers | 9 |
private sectors | 9 |
subjective physical | 9 |
social networks | 9 |
access health | 9 |
clinical signs | 9 |
diagnosed hiv | 9 |
health threats | 9 |
class ii | 9 |
expansion pulmonary | 9 |
recombinant human | 9 |
health disparities | 9 |
transcriptase inhibitors | 9 |
line treatment | 9 |
quality management | 9 |
related lipodystrophy | 9 |
rates among | 9 |
intestinal epithelial | 9 |
tb therapy | 9 |
dendritic cell | 9 |
high density | 9 |
severely ill | 9 |
society groups | 9 |
chronic alcohol | 9 |
ist es | 9 |
significant difference | 9 |
may affect | 9 |
influenza viruses | 9 |
issues associated | 9 |
wegen der | 9 |
closely related | 9 |
first year | 9 |
infections causing | 9 |
significant effect | 9 |
well documented | 9 |
organ transplantation | 9 |
health metrics | 9 |
one year | 9 |
marginalized populations | 9 |
lung biopsy | 9 |
another example | 9 |
sars crisis | 9 |
alveolar macrophages | 9 |
low levels | 9 |
lyapunov function | 9 |
first hiv | 9 |
information system | 9 |
order model | 9 |
haemophilus influenzae | 9 |
future studies | 9 |
hiv vaccines | 9 |
acute diarrhea | 9 |
individuals infected | 9 |
sex practices | 9 |
chronic obstructive | 9 |
following cancer | 9 |
new public | 9 |
epithelial cell | 9 |
specified conditions | 9 |
transmission occurs | 9 |
fractional derivatives | 9 |
low education | 9 |
social service | 9 |
twice daily | 9 |
community partners | 9 |
screening test | 9 |
aids will | 9 |
domestic animals | 9 |
bill melinda | 9 |
endemic area | 9 |
close contact | 9 |
bei schweren | 9 |
death rate | 9 |
initial conditions | 9 |
aerosolized pentamidine | 9 |
like hiv | 9 |
adenoviral vectors | 9 |
three groups | 9 |
chest radiographic | 9 |
wide variety | 9 |
highly correlated | 9 |
past two | 9 |
bronchopleural fi | 9 |
every year | 9 |
national center | 9 |
care facilities | 9 |
liposomal amphotericin | 9 |
central government | 9 |
study will | 9 |
driven mistrust | 9 |
inflammatory response | 9 |
preventive efforts | 9 |
prospective studies | 9 |
executive director | 9 |
autoimmune encephalomyelitis | 9 |
one hand | 9 |
deleterious effects | 9 |
symptomatic hiv | 9 |
viral molecules | 9 |
early years | 9 |
intellectual property | 9 |
donor screening | 9 |
limited access | 9 |
tuberculosis control | 9 |
jirovecii pneumonia | 9 |
secondary infections | 9 |
fl uconazole | 9 |
student zhao | 9 |
international securitization | 9 |
ist das | 9 |
six months | 9 |
attitudes towards | 9 |
pneumocystis jirovecii | 9 |
intracellulare complex | 9 |
criminal justice | 9 |
interstitial infiltrates | 9 |
among drug | 9 |
zahl der | 9 |
patchy shadows | 9 |
acquired hiv | 9 |
adenovirus serotype | 9 |
idiopathic esophageal | 9 |
may develop | 9 |
posttraumatic stress | 9 |
international human | 9 |
adult patients | 9 |
agent i | 9 |
cryptococcal disease | 9 |
economic growth | 9 |
benefit analysis | 9 |
viral diseases | 9 |
developed nations | 9 |
scientific evidence | 9 |
rhesus monkeys | 9 |
ist ein | 9 |
real life | 9 |
adverse events | 9 |
immune systems | 9 |
treatment regimens | 9 |
vaccine trials | 9 |
european countries | 9 |
nipah virus | 9 |
adenovirus type | 9 |
managed care | 9 |
past months | 9 |
health facilities | 9 |
intelligence service | 9 |
framework document | 9 |
mass shadows | 9 |
study also | 9 |
political will | 9 |
global community | 9 |
may need | 9 |
pulmonary diseases | 9 |
treatment program | 9 |
natural infection | 9 |
diarrh es | 9 |
social unrest | 9 |
sexual assault | 9 |
prospective cohort | 9 |
nations general | 9 |
bovine spongiform | 9 |
cell death | 9 |
susceptible population | 9 |
among sex | 9 |
systemic therapy | 9 |
incidence rate | 9 |
methadone maintenance | 9 |
rights recommend | 9 |
rights laws | 9 |
network theory | 9 |
tubercle bacillus | 9 |
preventing hiv | 9 |
china hiv | 9 |
local community | 9 |
cell leukemia | 9 |
newly infected | 9 |
medical research | 9 |
mediated immune | 9 |
chronically ill | 9 |
studies suggest | 9 |
like disease | 9 |
oral rehydration | 9 |
respiratory infections | 9 |
care unit | 9 |
total sample | 9 |
paper will | 9 |
und den | 9 |
blood borne | 9 |
may appear | 9 |
war ii | 9 |
data suggest | 9 |
sei i | 9 |
dans le | 9 |
direct contact | 9 |
case definition | 9 |
finden sich | 9 |
school age | 9 |
die durch | 9 |
line therapy | 9 |
may provide | 9 |
hiv clinic | 8 |
wird die | 8 |
upper respiratory | 8 |
political structure | 8 |
us cities | 8 |
energy expenditure | 8 |
clinical improvement | 8 |
greater risk | 8 |
brain barrier | 8 |
will discuss | 8 |
pulmonary abscess | 8 |
threatening illness | 8 |
respiratory syncytial | 8 |
joint united | 8 |
health response | 8 |
higher incidence | 8 |
two epidemics | 8 |
low prevalence | 8 |
see text | 8 |
ad vector | 8 |
many ways | 8 |
infected patient | 8 |
incident cases | 8 |
prevention services | 8 |
significant role | 8 |
host endocrine | 8 |
infected animals | 8 |
may include | 8 |
psychological distress | 8 |
immune suppression | 8 |
set point | 8 |
small group | 8 |
research process | 8 |
cell surface | 8 |
und damit | 8 |
hiv antibody | 8 |
tests performed | 8 |
may represent | 8 |
almost always | 8 |
increased mortality | 8 |
cell receptor | 8 |
villous atrophy | 8 |
patients hiv | 8 |
ngo community | 8 |
many developing | 8 |
special session | 8 |
month period | 8 |
global development | 8 |
diagnose einer | 8 |
prevalence rate | 8 |
hiv vulnerability | 8 |
diffi cile | 8 |
first years | 8 |
next generation | 8 |
skin lesions | 8 |
bei kindern | 8 |
effective way | 8 |
homosexual males | 8 |
critical role | 8 |
fl occulent | 8 |
myelin basic | 8 |
new infectious | 8 |
biomedical research | 8 |
health inequalities | 8 |
lymphoid interstitial | 8 |
plasma donors | 8 |
task force | 8 |
saharan african | 8 |
handelt es | 8 |
sexual experiences | 8 |
pneumocystis pneumonia | 8 |
persons infected | 8 |
management strategies | 8 |
fat malabsorption | 8 |
risky sexual | 8 |
esophageal complaints | 8 |
pneumocystis jiroveci | 8 |
progress toward | 8 |
care program | 8 |
medical denialism | 8 |
will likely | 8 |
put forward | 8 |
children infected | 8 |
premarital sex | 8 |
cat species | 8 |
health conditions | 8 |
health initiatives | 8 |
much less | 8 |
test results | 8 |
early childhood | 8 |
manifestations include | 8 |
growth hormone | 8 |
universal precautions | 8 |
les infections | 8 |
care professionals | 8 |
treatment outcomes | 8 |
giardia lamblia | 8 |
emergency department | 8 |
limited settings | 8 |
parasitic infections | 8 |
therapie der | 8 |
good governance | 8 |
health spending | 8 |
getting infected | 8 |
cellular automata | 8 |
autoimmunopathic destruction | 8 |
bei aids | 8 |
cancer survivors | 8 |
current hiv | 8 |
cigarette smoking | 8 |
previously mentioned | 8 |
health challenges | 8 |
health minister | 8 |
lyme disease | 8 |
advanced aids | 8 |
solid waste | 8 |
arterial oxygen | 8 |
chronic liver | 8 |
preliminary findings | 8 |
dengue hemorrhagic | 8 |
disease burden | 8 |
per unit | 8 |
economic status | 8 |
last decade | 8 |
basic protein | 8 |
auf eine | 8 |
herpes virus | 8 |
microscopic examination | 8 |
new vaccine | 8 |
sterile syringes | 8 |
community services | 8 |
include fever | 8 |
resistant tb | 8 |
outpatient care | 8 |
expert opinion | 8 |
less frequently | 8 |
written materials | 8 |
die erkrankung | 8 |
stool samples | 8 |
kann eine | 8 |
ca models | 8 |
phase ii | 8 |
overall health | 8 |
response categories | 8 |
therapie ist | 8 |
die von | 8 |
transthoracic needle | 8 |
caseous necrosis | 8 |
policy development | 8 |
cryptococcal iris | 8 |
fiv infection | 8 |
south asia | 8 |
infections caused | 8 |
trypanosoma cruzi | 8 |
ptg following | 8 |
moral failure | 8 |
experimental animals | 8 |
low grade | 8 |
dose policy | 8 |
molecular biology | 8 |
acute therapy | 8 |
response rate | 8 |
infection level | 8 |
disease associated | 8 |
aids denialism | 8 |
primary hiv | 8 |
medical records | 8 |
poor appetite | 8 |
mediastinal lymph | 8 |
wild animals | 8 |
risk behavior | 8 |
infektionen durch | 8 |
behavioural expectations | 8 |
body temperature | 8 |
latently infected | 8 |
young adult | 8 |
three decades | 8 |
new host | 8 |
cell immunity | 8 |
may play | 8 |
transcription factors | 8 |
yeast phase | 8 |
news media | 8 |
early detection | 8 |
regulatory cells | 8 |
global stability | 8 |
pulmonary barotrauma | 8 |
took place | 8 |
inhibitor therapy | 8 |
ca model | 8 |
heterosexual intercourse | 8 |
food intake | 8 |
rural communities | 8 |
ang ii | 8 |
healthcare providers | 8 |
aids securitization | 8 |
rubella syndrome | 8 |
der klinischen | 8 |
poor health | 8 |
confi ned | 8 |
marginalized groups | 8 |
node tuberculosis | 8 |
political leadership | 8 |
proposed model | 8 |
sierra leone | 8 |
dna vaccine | 8 |
aids date | 8 |
problems associated | 8 |
results show | 8 |
infektionen mit | 8 |
genetic diversity | 8 |
von neumann | 8 |
dna sequences | 8 |
human behaviour | 8 |
viral suppression | 8 |
significantly increased | 8 |
im rahmen | 8 |
den letzten | 8 |
will probably | 8 |
increasing access | 8 |
domestic cats | 8 |
cryptococcus gattii | 8 |
individuals living | 8 |
medical professionals | 8 |
economic conditions | 8 |
blood vessels | 8 |
bilateral donors | 8 |
copies ml | 8 |
ethnic minorities | 8 |
tuberculosis knockout | 8 |
three million | 8 |
extensively drug | 8 |
der erkrankung | 8 |
prevent infection | 8 |
disease threats | 8 |
diabetes mellitus | 8 |
generalized adams | 8 |
testing ethics | 8 |
infected female | 8 |
tube drainage | 8 |
pathog ne | 8 |
type lung | 8 |
highly effective | 8 |
case management | 8 |
emphasis added | 8 |
mhc class | 8 |
vancouver island | 8 |
adverse reactions | 8 |
monoclonal antibody | 8 |
first months | 8 |
nitric oxide | 8 |
auftreten von | 8 |
und mit | 8 |
highest rates | 8 |
world trade | 8 |
human security | 8 |
federal agencies | 8 |
community development | 8 |
bis zum | 8 |
among homosexual | 8 |
bei patienten | 8 |
chinese nationalism | 8 |
plasma cells | 8 |
multinational corporations | 8 |
international monetary | 8 |
hiv epidemics | 8 |
vor der | 8 |
endemic regions | 8 |
diseases will | 8 |
des infections | 8 |
central asia | 8 |
borne disease | 8 |
hilar lymph | 8 |
cords liked | 8 |
herpes zoster | 8 |
early hiv | 8 |
disease free | 8 |
european union | 8 |
hiv incidence | 8 |
revised ihrs | 8 |
immunization programs | 8 |
large scale | 8 |
cell types | 8 |
ngo participation | 8 |
cases without | 8 |
research center | 8 |
au sein | 8 |
antiretrovirale therapie | 8 |
patients without | 8 |
new approaches | 8 |
chinese leadership | 8 |
es gibt | 8 |
health program | 8 |
community leaders | 8 |
will require | 8 |
advanced stages | 8 |
mit den | 8 |
mean score | 8 |
host governments | 8 |
cell response | 8 |
health communities | 8 |
african americans | 8 |
family physicians | 8 |
field epidemiology | 8 |
ssa countries | 8 |
compromised immunity | 8 |
primary prevention | 8 |
street health | 7 |
health importance | 7 |
growth following | 7 |
educational materials | 7 |
cell culture | 7 |
folinic acid | 7 |
acute pulmonary | 7 |
chronic fatigue | 7 |
der regel | 7 |
national policies | 7 |
public support | 7 |
health related | 7 |
better health | 7 |
per se | 7 |
uncomplicated measles | 7 |
also used | 7 |
neumann neighborhood | 7 |
critical reflection | 7 |
legal status | 7 |
individual human | 7 |
peptic ulcer | 7 |
data collected | 7 |
giant cells | 7 |
older children | 7 |
improving health | 7 |
decision makers | 7 |
far greater | 7 |
diagnostic test | 7 |
new urban | 7 |
hiv science | 7 |
der blutkultur | 7 |
new human | 7 |
cost benefit | 7 |
exposure prophylaxis | 7 |
human coronaviruses | 7 |
fi ne | 7 |
human health | 7 |
infection hiv | 7 |
ulcer disease | 7 |
health departments | 7 |
adjustment relationship | 7 |
immunization coverage | 7 |
die sich | 7 |
die zahl | 7 |
may remain | 7 |
information systems | 7 |
haart accessibility | 7 |
bei uns | 7 |
lower lungs | 7 |
community involvement | 7 |
ct fi | 7 |
past decades | 7 |
cns involvement | 7 |
often occurs | 7 |
democratic republic | 7 |
die hiv | 7 |
oral fluconazole | 7 |
urban area | 7 |
simulation results | 7 |
individual cases | 7 |
financial support | 7 |
pharmaceutical companies | 7 |
dass die | 7 |
clinical outcomes | 7 |
worm infections | 7 |
first reported | 7 |
migrant workers | 7 |
will become | 7 |
virus hiv | 7 |
innate immunity | 7 |
based violence | 7 |
systematic analysis | 7 |
hiv type | 7 |
bacterial pathogens | 7 |
antibiotic treatment | 7 |
un general | 7 |
vaccination strategies | 7 |
obstructive pulmonary | 7 |
qualitative data | 7 |
new law | 7 |
humoral immunity | 7 |
small nodules | 7 |
common among | 7 |
aids hiv | 7 |
isospora belli | 7 |
sputum culture | 7 |
i wish | 7 |
infection stages | 7 |
pulmonary fungal | 7 |
bei einigen | 7 |
immunocompetent patients | 7 |
written material | 7 |
abuse treatment | 7 |
promote health | 7 |
density shadows | 7 |
chinese population | 7 |
vicious circle | 7 |
sectional study | 7 |
visual loss | 7 |
rate among | 7 |
significantly reduces | 7 |
yunnan province | 7 |
rna levels | 7 |
political space | 7 |
local stability | 7 |
antibiotic use | 7 |
will need | 7 |
providing health | 7 |
growth factor | 7 |
neoformans var | 7 |
sars patients | 7 |
infections among | 7 |
cavity lesions | 7 |
aids era | 7 |
high rate | 7 |
aids outcomes | 7 |
international concern | 7 |
interstitial fi | 7 |
incubation periods | 7 |
healthcare system | 7 |
upper lobe | 7 |
boost vaccination | 7 |
many asian | 7 |
immunocompetent individuals | 7 |
subcutaneous emphysema | 7 |
immune restoration | 7 |
pulmonary coccidioidomycosis | 7 |
i think | 7 |
within years | 7 |
calcifi cation | 7 |
often seen | 7 |
patients suffering | 7 |
tb patients | 7 |
two different | 7 |
viral etiology | 7 |
almost every | 7 |
sexually active | 7 |
may involve | 7 |
die infektion | 7 |
international partners | 7 |
two thirds | 7 |
pharmaceutical company | 7 |
cryptococcal immune | 7 |
health doi | 7 |
antiretroviral therapies | 7 |
treatment guidelines | 7 |
rapid response | 7 |
infection rate | 7 |
western blot | 7 |
es zur | 7 |
first case | 7 |
will focus | 7 |
hiv among | 7 |
ebola outbreak | 7 |
excess mortality | 7 |
infected macrophages | 7 |
downtown toronto | 7 |
human resources | 7 |
disseminated mac | 7 |
within weeks | 7 |
special stains | 7 |
among african | 7 |
next years | 7 |
endangered species | 7 |
antifungal treatment | 7 |
des erregers | 7 |
minority immigrants | 7 |
small quantity | 7 |
hiv stigma | 7 |
cytomegalovirus infection | 7 |
low cost | 7 |
linear shadows | 7 |
respiratory infection | 7 |
relatively low | 7 |
xylose absorption | 7 |
mg daily | 7 |
intravenous pentamidine | 7 |
community based | 7 |
eis program | 7 |
care costs | 7 |
cell wall | 7 |
positive results | 7 |
gene products | 7 |
countries like | 7 |
alveolar space | 7 |
blood mononuclear | 7 |
eighteenth century | 7 |
werden die | 7 |
antiretroviral medications | 7 |
mg twice | 7 |
health report | 7 |
study population | 7 |
support groups | 7 |
maintenance treatment | 7 |
auf den | 7 |
laboratory strategic | 7 |
neoformans infection | 7 |
current political | 7 |
aids problems | 7 |
three types | 7 |
classifi cation | 7 |
infected mothers | 7 |
tb treatment | 7 |
white house | 7 |
hiv gp | 7 |
related issues | 7 |
patients undergoing | 7 |
case definitions | 7 |
host species | 7 |
nineteenth century | 7 |
contact tracing | 7 |
hilar lymphadenectasis | 7 |
streptococcus pneumoniae | 7 |
virulence factors | 7 |
low perceived | 7 |
reconstitution disease | 7 |
syncytial virus | 7 |
health responses | 7 |
der lunge | 7 |
central china | 7 |
human cells | 7 |
common source | 7 |
art era | 7 |
le taux | 7 |
nursing heroism | 7 |
i will | 7 |
may increase | 7 |
esophageal ulcers | 7 |
rapidly progressive | 7 |
resource allocation | 7 |
increased rates | 7 |
neben der | 7 |
serious public | 7 |
kann es | 7 |
disease occurs | 7 |
lung function | 7 |
may show | 7 |
cancer cells | 7 |
der wahl | 7 |
physician visits | 7 |
medical practice | 7 |
needle biopsy | 7 |
line drugs | 7 |
diss min | 7 |
scientific community | 7 |
chemical pleurodesis | 7 |
lorsque le | 7 |
contaminated water | 7 |
mucosal immune | 7 |
based organizations | 7 |
clinical response | 7 |
effective art | 7 |
invasive aspergillosis | 7 |
last year | 7 |
blood gas | 7 |
care programs | 7 |
lung markings | 7 |
social security | 7 |
mit hoher | 7 |
aids std | 7 |
social network | 7 |
safer sex | 7 |
serum levels | 7 |
sars virus | 7 |
million individuals | 7 |
just one | 7 |
traditional treatments | 7 |
rehydration therapy | 7 |
cryptococcal infections | 7 |
sexual encounters | 7 |
intestinal function | 7 |
mild cases | 7 |
aids problem | 7 |
fi broblasts | 7 |
hepatocellular carcinoma | 7 |
fast bacilli | 7 |
steady state | 7 |
common bacterial | 7 |
acute bacterial | 7 |
complex infection | 7 |
individuals aware | 7 |
urban slums | 7 |
antimalarial drugs | 7 |
blood fl | 7 |
legionnaires disease | 7 |
significant reduction | 7 |
peer review | 7 |
sexual partner | 7 |
sexual behaviors | 7 |
associated immune | 7 |
higher rates | 7 |
educational interventions | 7 |
aids orphans | 7 |
moore neighborhood | 7 |
pulmonary tb | 7 |
die gesundheit | 7 |
lung transplantation | 7 |
specifi city | 7 |
infection stage | 7 |
candida species | 7 |
antivirale therapie | 7 |
proposed fractional | 7 |
eye examination | 7 |
chinese authorities | 7 |
atypical mycobacteria | 7 |
mdm snp | 7 |
verbesserung der | 7 |
art treatment | 7 |
stress management | 7 |
prophylactic hiv | 7 |
new challenges | 7 |
local government | 7 |
amino acids | 7 |
per patient | 7 |
coronavirus disease | 7 |
active participation | 7 |
nach dem | 7 |
donor funding | 7 |
significant impact | 7 |
may explain | 7 |
racial ethnic | 7 |
cell populations | 7 |
national identity | 7 |
local level | 7 |
thickened pulmonary | 7 |
us centers | 7 |
significant differences | 7 |
health department | 7 |
newly diagnosed | 7 |
wbc count | 7 |
member countries | 7 |
research program | 7 |
environmental conditions | 7 |
antiretroviral agents | 7 |
care team | 7 |
available data | 7 |
bei erwachsenen | 7 |
drug toxicity | 7 |
studies indicate | 7 |
adults aged | 7 |
computed tomography | 7 |
carbohydrate malabsorption | 7 |
blood collection | 7 |
triple combination | 7 |
testing opportunities | 7 |
dental care | 7 |
nasogastric tube | 7 |
unit time | 7 |
urgent need | 7 |
nonhuman primates | 7 |
urban populations | 7 |
es nicht | 7 |
humoral immune | 7 |
international law | 7 |
physical distancing | 7 |
property rights | 7 |
medical education | 7 |
infections associated | 7 |
limited resources | 7 |
occult pneumothorax | 7 |
effective public | 7 |
emergency departments | 7 |
personal susceptibility | 7 |
thematic analysis | 7 |
specific cd | 7 |
systemic infection | 7 |
higher levels | 7 |
increase access | 7 |
cases involving | 7 |
third world | 7 |
induced sputum | 7 |
systemic immune | 7 |
bcg vaccine | 7 |
phase clinical | 7 |
im vordergrund | 7 |
dental hygienist | 7 |
epidemic among | 7 |
global infectious | 7 |
china moh | 7 |
public awareness | 7 |
infection rates | 7 |
depressive symptoms | 7 |
parasitic infection | 7 |
provide protection | 7 |
transgene expression | 7 |
almost exclusively | 7 |
large urban | 7 |
different types | 7 |
zu sein | 7 |
control efforts | 7 |
und des | 7 |
lessons learned | 7 |
provide information | 7 |
cvd risk | 7 |
patients develop | 7 |
aids vulnerability | 7 |
based participatory | 7 |
gegensatz zu | 7 |
relational autonomy | 7 |
us national | 7 |
marneffei infection | 7 |
two patients | 7 |
visceral leishmaniasis | 7 |
confi rmed | 7 |
medical history | 7 |
active disease | 7 |
unaware infectives | 7 |
serologic tests | 7 |
positive mothers | 7 |
pleural cavity | 7 |
telephone survey | 7 |
bis zu | 7 |
symptoms may | 7 |
aids infection | 7 |
protective efficacy | 7 |
may take | 7 |
memory cd | 7 |
case report | 7 |
microbial translocation | 7 |
mental illness | 7 |
gene therapy | 7 |
order desire | 7 |
target populations | 7 |
high perceived | 7 |
naked dna | 7 |
ks lesions | 6 |
bloody diarrhea | 6 |
middle stage | 6 |
peuvent tre | 6 |
term follow | 6 |
einer der | 6 |
haart initiation | 6 |
intervention studies | 6 |
nutrient intake | 6 |
cause pulmonary | 6 |
will make | 6 |
sars cases | 6 |
hiv acquisition | 6 |
american men | 6 |
world population | 6 |
antigen capsid | 6 |
cause acute | 6 |
aids virus | 6 |
stress disorder | 6 |
mit sehr | 6 |
newly identified | 6 |
social work | 6 |
prp sc | 6 |
mortality associated | 6 |
approximately million | 6 |
symptomatic patients | 6 |
deliberate use | 6 |
domestic violence | 6 |
intervention strategies | 6 |
feeding practices | 6 |
body composition | 6 |
two testing | 6 |
medical science | 6 |
local communities | 6 |
fi eld | 6 |
readily available | 6 |
positive persons | 6 |
target cells | 6 |
many young | 6 |
aspergillar glomera | 6 |
community resources | 6 |
country coordinating | 6 |
children born | 6 |
control programs | 6 |
antiviralen therapie | 6 |
apparently immunocompetent | 6 |
night sweating | 6 |
social factors | 6 |
protein vpr | 6 |
geopolitical stability | 6 |
basic health | 6 |
aids among | 6 |
hiv spread | 6 |
related disease | 6 |
coccidioides immitis | 6 |
bronchial wall | 6 |
two diseases | 6 |
person living | 6 |
acute sero | 6 |
population growth | 6 |
hiv pathogenesis | 6 |
des immunsystems | 6 |
survival benefit | 6 |
infektion und | 6 |
across canada | 6 |
selection bias | 6 |
technical assistance | 6 |
antigen testing | 6 |
next decade | 6 |
liver biopsy | 6 |
syndrome coronavirus | 6 |
many factors | 6 |
risk management | 6 |
side effect | 6 |
early lesions | 6 |
von infektionen | 6 |
african population | 6 |
birth defects | 6 |
pediatric population | 6 |
autosomal dominant | 6 |
transfusion recipients | 6 |
epidemic spread | 6 |
negative impact | 6 |
fluconazole resistance | 6 |
absorptive capacity | 6 |
marked increase | 6 |
next step | 6 |
important cause | 6 |
defi ciency | 6 |
disseminated intravascular | 6 |
may persist | 6 |
high degree | 6 |
new approach | 6 |
major problem | 6 |
ad hexon | 6 |
often shows | 6 |
disease information | 6 |
viral pathogens | 6 |
virusinfected patients | 6 |
animal model | 6 |
sided pneumothorax | 6 |
dependent adenoviral | 6 |
gp cytotoxic | 6 |
esophageal disease | 6 |
liver failure | 6 |
oral lesions | 6 |
young women | 6 |
treatment may | 6 |
health providers | 6 |
empirical evidence | 6 |
hiv coinfected | 6 |
heavy burden | 6 |
borne diseases | 6 |
und werden | 6 |
le patient | 6 |
recent studies | 6 |
authors declare | 6 |
multiple drug | 6 |
pulmonary lesions | 6 |
campylobacter jejuni | 6 |
term therapy | 6 |
affect hiv | 6 |
international peace | 6 |
premature mortality | 6 |
serious illness | 6 |
cases may | 6 |
cases per | 6 |
std prevention | 6 |
prospective randomized | 6 |
phase iii | 6 |
biogroup aegyptius | 6 |
antibody production | 6 |
death rates | 6 |
fungal stains | 6 |
er op | 6 |
section ii | 6 |
cohort studies | 6 |
least days | 6 |
pulmonary manifestations | 6 |
sputum smear | 6 |
analyzed using | 6 |
zoonotic diseases | 6 |
adjustment outcome | 6 |
acute lung | 6 |
negative relationship | 6 |
preventive health | 6 |
strengthening hiv | 6 |
blood transfusions | 6 |
global level | 6 |
mortality among | 6 |
chinese msm | 6 |
lymphocyte activation | 6 |
also increased | 6 |
severe pcp | 6 |
also reported | 6 |
nonlinear fractional | 6 |
speci fi | 6 |
us president | 6 |
oder als | 6 |
opportunistic pathogens | 6 |
receiving treatment | 6 |
complications associated | 6 |
teaching hospital | 6 |
wide spectrum | 6 |
rights issue | 6 |
first use | 6 |
life cycle | 6 |
immunodeficiency viruses | 6 |
mucosal cd | 6 |
veterans affairs | 6 |
services use | 6 |
falciparum malaria | 6 |
health practice | 6 |
viral loads | 6 |
immunodeficiency virusinfected | 6 |
patients immunocompromis | 6 |
appropriate treatment | 6 |
pet ownership | 6 |
child care | 6 |
provide care | 6 |
perinatal transmission | 6 |
new vaccines | 6 |
order sei | 6 |
folic acid | 6 |
iom report | 6 |
care delivery | 6 |
sich die | 6 |
later stages | 6 |
community engagement | 6 |
people worldwide | 6 |
two distinct | 6 |
cd cd | 6 |
significantly reduced | 6 |
die wichtigsten | 6 |
und nicht | 6 |
bronchial obstruction | 6 |
bubonic plague | 6 |
positive change | 6 |
order values | 6 |
associated lymphoid | 6 |
may reveal | 6 |
transfusion transmission | 6 |
first aids | 6 |
host immunity | 6 |
threat posed | 6 |
guidance note | 6 |
country level | 6 |
fungal phase | 6 |
related health | 6 |
family medicine | 6 |
biopsy specimens | 6 |
derivative order | 6 |
hiv hcv | 6 |
anal sex | 6 |
standard therapy | 6 |
using condoms | 6 |
especially among | 6 |
structured interviews | 6 |
sexual violence | 6 |
take preventive | 6 |
routine chest | 6 |
race ethnicity | 6 |
recent immigrants | 6 |
blown aids | 6 |